K. O. Onyango

Building Capability for Clinical Pharmacology Research in Sub‐Saharan Africa

C. Masimirembwa, B. Ogutu, S. Owusu-Agyei, 2017, Clinical pharmacology and therapeutics.

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, The Lancet. Infectious Diseases.

Implementation and Operational Research: Correlates of Adherence and Treatment Failure Among Kenyan Patients on Long-term Highly Active Antiretroviral Therapy

B. Ogutu, R. Aman, J. Kinyua, 2015, Journal of acquired immune deficiency syndromes.

Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study

L. Otieno, B. Ogutu, D. J. Perkins, 2014, Malaria Journal.

What determines consumption of nutritious foods by the urban poor in Africa?

C. Chege, Mercy M. Mutua, K. O. Onyango, 2021, British Food Journal.

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, The Lancet. Infectious Diseases.

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, Lancet. Infectious Diseases (Print).

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, The Lancet. Infectious diseases.